These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


355 related items for PubMed ID: 21199524

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Treatment of chronic hepatitis B: Evolution over two decades.
    Yuen MF, Lai CL.
    J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():138-43. PubMed ID: 21199525
    [Abstract] [Full Text] [Related]

  • 3. Prevention of hepatocellular carcinoma in hepatitis B virus infection.
    Lim SG, Mohammed R, Yuen MF, Kao JH.
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1352-7. PubMed ID: 19702903
    [Abstract] [Full Text] [Related]

  • 4. Incidence and determinants of spontaneous hepatitis B surface antigen seroclearance: a community-based follow-up study.
    Liu J, Yang HI, Lee MH, Lu SN, Jen CL, Wang LY, You SL, Iloeje UH, Chen CJ, REVEAL-HBV Study Group.
    Gastroenterology; 2010 Aug; 139(2):474-82. PubMed ID: 20434450
    [Abstract] [Full Text] [Related]

  • 5. On-treatment monitoring of chronic hepatitis B virus infection: an Asian-Pacific perspective.
    Chien RN.
    J Gastroenterol Hepatol; 2010 May; 25(5):852-7. PubMed ID: 20546437
    [Abstract] [Full Text] [Related]

  • 6. Nucleos(t)ide analogues only induce temporary hepatitis B e antigen seroconversion in most patients with chronic hepatitis B.
    Reijnders JG, Perquin MJ, Zhang N, Hansen BE, Janssen HL.
    Gastroenterology; 2010 Aug; 139(2):491-8. PubMed ID: 20381492
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Hepatitis B viral factors and clinical outcomes of chronic hepatitis B.
    Lin CL, Kao JH.
    J Biomed Sci; 2008 Mar; 15(2):137-45. PubMed ID: 18058038
    [Abstract] [Full Text] [Related]

  • 11. Estimating the future health burden of chronic hepatitis B and the impact of therapy in Spain.
    Idris BI, Brosa M, Richardus JH, Esteban R, Schalm SW, Buti M.
    Eur J Gastroenterol Hepatol; 2008 Apr; 20(4):320-6. PubMed ID: 18334876
    [Abstract] [Full Text] [Related]

  • 12. Long-term follow-up of patients with hepatitis B e antigen negative chronic hepatitis B.
    Bekku D, Arai M, Imazeki F, Yonemitsu Y, Kanda T, Fujiwara K, Fukai K, Sato K, Itoga S, Nomura F, Yokosuka O.
    J Gastroenterol Hepatol; 2011 Jan; 26(1):122-8. PubMed ID: 21175805
    [Abstract] [Full Text] [Related]

  • 13. Hepatitis B virus DNA and hepatitis B surface antigen levels in chronic hepatitis B.
    Fung J, Lai CL, Yuen MF.
    Expert Rev Anti Infect Ther; 2010 Jun; 8(6):717-26. PubMed ID: 20521898
    [Abstract] [Full Text] [Related]

  • 14. Global perspective on the natural history of chronic hepatitis B: role of hepatitis B virus genotypes A to J.
    Liu CJ, Kao JH.
    Semin Liver Dis; 2013 May; 33(2):97-102. PubMed ID: 23749665
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A multi-center open study to determine the effect of lamivudine on HBV DNA clearance and to assess the safety of the regimen in patients with chronic hepatitis B infection.
    Mazur W, Król F, Cianciara J, Nazzal K, Gładysz A, Juszczyk J, Bolewska B, Adamek J, Czajka B, Swietek K, Kryczka W, Gonciarz Z.
    Med Sci Monit; 2002 Apr; 8(4):CR257-62. PubMed ID: 11951067
    [Abstract] [Full Text] [Related]

  • 17. Clinical significance and evolution of core promoter and precore mutations in HBeAg-positive patients with HBV genotype B and C: a longitudinal study.
    Chen CH, Lee CM, Hung CH, Hu TH, Wang JH, Wang JC, Lu SN, Changchien CS.
    Liver Int; 2007 Aug; 27(6):806-15. PubMed ID: 17617124
    [Abstract] [Full Text] [Related]

  • 18. New advances in chronic hepatitis B.
    Tujios SR, Lee WM.
    Curr Opin Gastroenterol; 2012 May; 28(3):193-7. PubMed ID: 22450894
    [Abstract] [Full Text] [Related]

  • 19. The role of serial measurement of serum HBV DNA levels in patients with chronic HBeAg(-) hepatitis B infection: association with liver disease progression. A prospective cohort study.
    Zacharakis G, Koskinas J, Kotsiou S, Tzara F, Vafeiadis N, Papoutselis M, Maltezos E, Sivridis E, Papoutselis K.
    J Hepatol; 2008 Dec; 49(6):884-91. PubMed ID: 18674840
    [Abstract] [Full Text] [Related]

  • 20. Evidence for the insufficient evaluation and undertreatment of chronic hepatitis B infection in a predominantly low-income and immigrant population.
    Jung CW, Tan J, Tan N, Kuo MN, Ashok A, Eells SJ, Miller LG.
    J Gastroenterol Hepatol; 2010 Feb; 25(2):369-75. PubMed ID: 19929923
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.